Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

TRICARE getting retroactive rebates

Executive Summary

Manufacturers of drugs dispensed through the TRICARE retail pharmacy program were subject to the ceiling price as of Jan. 28, 2008, and are therefore subject to a refund for the difference in price paid, the Department of Defense says in a March 17 final rule implementing provisions of the National Defense Authorization Act for 2008. Manufacturers may seek a waiver or compromise in the refund amount, but refund payments for utilization data from Jan. 28 through Dec. 31, 2008 are due May 26. Manufacturer groups submitted comments arguing against making the refund retroactive (1"The Pink Sheet," Sept. 29, 2008, p. 13)
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS050866

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel